Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis

被引:139
作者
Jian, B
Jones, PL
Li, QY
Mohler, ER
Schoen, FJ
Levy, RJ
机构
[1] Childrens Hosp Philadelphia, Cardiol Res Lab, Philadelphia, PA 19104 USA
[2] Univ Penn Hlth Syst, Dept Med, Philadelphia, PA USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0002-9440(10)61698-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We previously showed that the expression of tenascin (TN-C), an extracellular matrix glycoprotein found in developing bone and atherosclerotic plaque, and matrix metalloproteinase-2 (MMP-2) are coordinated and Interdependent in cultured vascular smooth muscle cells. In this study, we hypothesized that TN-C and MMP-2 are mechanistically involved in the pathobiology of calcific aortic stenosis. Human calcific aortic stenosis cusps demonstrated immunohistochemically prominent deposition of TN-C, MMP-2, and alkaline phosphatase activity, as well as MMP-2 gelatinolytic activity. Although far lesser amounts of TN-C were noted in several of the grossly non-calcified valve cusps, MMP-2 and AP were never detected. Further, when aortic valve interstitial cells (both sheep and human) were cultivated on collagen supplemented with TN-C, both MMP-2 mRNA expression and MMP-2 gelatinolytic activity (both pro and active forms), were up-regulated compared to control. These observations support the view that accumulation of first TN-C and then MMP-2 are associated with progression of calcification. The residual presence of these proteins in severe calcifications is indicative of their involvement in the pathogenesis.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 33 条
  • [1] ANDERSON HC, 1989, LAB INVEST, V60, P320
  • [2] Balica M, 1997, CIRCULATION, V95, P1954
  • [3] Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis
    Bini, A
    Mann, KG
    Kudryk, BJ
    Schoen, FJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) : 1852 - 1861
  • [4] BONE MORPHOGENETIC PROTEIN EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS
    BOSTROM, K
    WATSON, KE
    HORN, S
    WORTHAM, C
    HERMAN, IM
    DEMER, LL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1800 - 1809
  • [5] Connolly JM, 1997, INT J ONCOL, V10, P71
  • [6] COWAN K, 1997, CIRCULATION S, V1, P243
  • [7] Matrix metalloproteinase expression in nonrheumatic aortic stenosis
    Edep, ME
    Shirani, J
    Wolf, P
    Brown, DL
    [J]. CARDIOVASCULAR PATHOLOGY, 2000, 9 (05) : 281 - 286
  • [8] TENASCIN - AN EXTRACELLULAR-MATRIX PROTEIN PROMINENT IN SPECIALIZED EMBRYONIC-TISSUES AND TUMORS
    ERICKSON, HP
    BOURDON, MA
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1989, 5 : 71 - 92
  • [9] HURLE JM, 1990, ANAT EMBRYOL, V181, P149
  • [10] Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system
    Jo, Y
    Yeon, J
    Kim, HJ
    Lee, ST
    [J]. BIOCHEMICAL JOURNAL, 2000, 345 : 511 - 519